Cardiac Arrhythmias 2001: Proceedings of the 7th International Workshop on Cardiac Arrhythmias (Venice, 7–10 October 2001)

Front Matter....Pages I-XX
Front Matter....Pages 1-1
Progress in Arrhythmia and Sudden Cardiac Death Research Support....Pages 3-10
Front Matter....Pages 11-11
Syncope or Drop Attack?....Pages 13-18
Syncope or Seizures: What Have We Learned from Electrocardiographic Monitoring?....Pages 19-21
Postprandial Hypotension: Pathophysiology and Management....Pages 22-28
Psychogenic Syncope: How Frequent Is It?....Pages 29-37
Syncope with Exercise: Mechanisms and Management....Pages 38-42
The Postural Tachycardia Syndrome: Etiology, Diagnosis and Treatment....Pages 43-49
Syncope in Hypertrophic Cardiomyopathy: What are the Potential Mechanisms and Therapeutic Implications?....Pages 50-56
Intraventricular Conduction Disturbances and Negative Electrophysiologic Study in Patients with Syncope: What Should One Do?....Pages 57-60
Unexplained Syncope with Inducible Sustained Ventricular Arrhythmias: to Implant or Not to Implant an ICD?....Pages 61-66
Syncope and ICD: What Are the Implications and Recommendations for Driving?....Pages 67-74
Therapy of Vasovagal Syncope: Is There a Role for Drugs Today?....Pages 75-82
Pacing for Vasovagal Syncope: Real Efficacy or Placebo Effect?....Pages 83-89
Prevention of Vasovagal Syncope by Pacing: How to Select Patients and Which Pacing Mode to Choose....Pages 90-96
Front Matter....Pages 97-97
How Many Patients Really Need Ventricular Resynchronization Therapy?....Pages 99-102
What Are the Clinical Benefits of Biventricular Pacing in Heart Failure Patients?....Pages 103-108
Neurohormonal and Anatomical Remodeling After Ventricular Resynchronization Therapy: Does It Really Happen?....Pages 109-113
Is Echocardiography Useful for Selecting Patients with Heart Failure as Candidates for Ventricular Resynchronization Therapy?....Pages 114-120
Is Acute Hemodynamic-Angiographic Evaluation Necessary Before Implantation of a Left Ventricular-Based Pacemaker?....Pages 121-124
Cardiac Resynchronization Therapy: Is There Any Correlation Between Pacing Site and Hemodynamic Improvement?....Pages 125-133
Front Matter....Pages 97-97
Does Atrial Resynchronization Confer Further Benefit on Patients Undergoing Ventricular Resynchronization Therapy?....Pages 134-139
Ventricular Resynchronization Therapy in Heart Failure Patients with Chronic Atrial Fibrillation: Is It Worthwhile ?....Pages 140-146
Ventricular Resynchronization Therapy: How to Follow Implanted Patients....Pages 147-150
How Great Is the Arrhythmic Risk for Heart Failure Patients and Does Resynchronization Therapy Modify It?....Pages 151-156
Does Cardiac Resynchronization Therapy Diminish the Need for Tachyarrhythmia Therapy?....Pages 157-162
Patients Undergoing ICD Implantation: How Many Need Biventricular Pacing?....Pages 163-169
Multisite Pacing in ICD Patients: Which Benefits?....Pages 170-180
Ventricular Resynchronization: What May We Expect from Technological Advances?....Pages 181-184
Front Matter....Pages 185-185
Catecholaminergic Polymorphic Ventricular Tachycardia: Another Inherited Arrhythmia?....Pages 187-190
The Link Between SIDS and Long QT Syndrome: from Theory to Evidence....Pages 191-197
Brugada Sign: What Is the Prevalence in an Apparently Healthy Population?....Pages 198-205
Asymptomatic Patients with Brugada Syndrome: Does the Risk of Sudden Death Justify ICD Implantation?....Pages 206-211
Will the Spectrum of Ion Channel Diseases Increase Further in the Near Future?....Pages 212-218
Left Ventricular Hypertrophy: A Neglected Risk Factor for Sudden Cardiac Death?....Pages 219-227
Post-Extrasystolic Heart Rate Turbulence as a Risk Predictor: What are the Perspectives and Limitations?....Pages 228-236
T-Wave Alternans, a Powerful Index for Malignant Ventricular Arrhythmias-Fact or Fiction?....Pages 237-247
Prevention of Sudden Death in Different Realities: Can We Reach a Consensus?....Pages 248-253
Drug Prevention of Sudden Death after Myocardial Infarction: Role of Angiotensin Converting Enzyme Inhibitors....Pages 254-257
Post-Infarction: When and How to Use Amiodarone....Pages 258-260
Amiodarone and ß-Blockers: Why This Combination?....Pages 261-265
Front Matter....Pages 185-185
Impact of MADIT and MUSTT on Clinical Practice....Pages 266-270
How Many ICD Recipients Really Need Dual-Chamber Pacing?....Pages 271-280
Front Matter....Pages 281-281
Acute Termination of Atrial Flutter: Are New Class Antiarrhythmic Drugs the Best Choice?....Pages 283-290
Typical Atrial Flutter: Antiarrhythmic Drugs or Ablation as First-Line Therapy?....Pages 291-300
What Is the Most Accurate and Simple Method to Assess Block Through the Cavotricuspid Isthmus?....Pages 301-305
Class IC/Amiodarone Atrial Flutter: What Are the Long-Term Results of Radiofrequency Ablation?....Pages 306-312
Diagnosis and Treatment of Atrial Flutter Circuits....Pages 313-319
Is Inappropriate Sinus Tachycardia Really Inappropriate?....Pages 320-323
“Pill in The Pocket” or Chronic Drug Prophylaxis for Patients with Paroxysmal Supraventricular Tachycardias without Indication for Catheter Ablation?....Pages 324-328
Ablation of Fast and/or Slow Pathway for AV Nodal Reentrant Tachycardia: What Is the Risk of Late Block?....Pages 329-335
What Are the Accuracy and Limitations of Published Algorithms Using Surface ECG to Localize Overt AV Accessory Pathways?....Pages 336-342
Front Matter....Pages 343-343
Electrical and Mechanical Remodeling of the Atria: What Are the Underlying Mechanisms, the Time Course and the Clinical Relevance?....Pages 345-352
“Lone” Atrial Fibrillation: How “Lone” Is It?....Pages 353-355
Focal Atrial Fibrillation: Which Clinical/Electrocardiographic Pattern?....Pages 356-360
Atrial Fibrillation Complicated by Heart Failure: First the Chicken or First the Egg?....Pages 361-368
Asymptomatic Atrial Fibrillation: How Frequent Is It? What Are the Practical/Therapeutic Implications?....Pages 369-372
Does Early Echocardiography-Guided Cardioversion of Atrial Fibrillation Prevent Electrical/Mechanical Remodeling of the Atria?....Pages 373-377
The “Pill in the Pocket” Approach for Paroxysmal Atrial Fibrillation: How Effective and Safe Is It?....Pages 378-382
Class IC Drug Plus Ibutilide for Acute Cardioversion of Atrial Fibrillation: What Is the Rationale and What Are the Results?....Pages 383-388
What Is the Role of Internal Low-Energy Cardioversion Today, in the Era of External Biphasic Shock?....Pages 389-393
Front Matter....Pages 343-343
Early Recurrences of Atrial Fibrillation: How to Predict and Avoid Them?....Pages 394-400
Reversal of Atrial Stunning After Cardioversion: What Are the Time Course and Clinical-Therapeutic Implications?....Pages 401-406
Signal-Averaged P-Wave: How Useful Is It in Identifying Patients at High Risk of Recurrences after Cardioversion?....Pages 407-412
Prevention of Atrial Fibrillation: Is Amiodarone a First Choice?....Pages 413-417
Antiarrhythmic Drug Prophylaxis to Avoid Permanent Atrial Fibrillation: Is it Worthwhile?....Pages 418-421
Antiplatelet Agents for Prevention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One?....Pages 422-435
Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It?....Pages 436-440
Front Matter....Pages 441-441
Focal Atrial Fibrillation: The Bordeaux Experience....Pages 443-446
Milan Experience of Catheter Ablation for Atrial Fibrillation....Pages 447-452
Catheter Ablation of Focal Atrial Fibrillation: Taiwan Experience....Pages 453-456
Ablation of Atrial Fibrillation: The Cleveland Clinic Experience....Pages 457-464
Worldwide Experience in Surgical Treatment of Atrial Fibrillation....Pages 465-468
Surgical Treatment of Atrial Fibrillation: The Japanese Experience....Pages 469-474
Intraoperative Radiomaze for Atrial Fibrillation Patients Undergoing Heart Surgery: Which Acute and Long Term Results?....Pages 475-478
Implantable Atrial Defibrillator: Where Are We and Where Are We Going?....Pages 479-484
Atrial Pacing to Prevent Atrial Fibrillation: Is There Any Evidence of Its Real Efficacy?....Pages 485-491
Is Overdrive Pacing Useful for the Prevention of Paroxysmal Atrial Fibrillation?....Pages 492-497
Which Patients with Atrial Fibrillation Benefit Most from Overdrive Pacing?....Pages 498-503
Brady-Tachy Syndrome: What Is the Best Pacing Technique To Reduce the Burden of Atrial Fibrillation?....Pages 504-509
Patients with Paroxysmal Atrial Fibrillation Undergoing “Ablate and Pace” Therapy: Is Prevention of Arrhythmic Recurrences Possible by Combined Overdrive and Biatrial Pacing?....Pages 510-518
Front Matter....Pages 441-441
ICD Patients: What Is the Efficacy of Early Activation of Atrial ATP Therapies in Atrial Fibrillation Termination?....Pages 519-522
Might a Better Understanding of Atrial Electrophysiology Help Atrial Fibrillation Treatment?....Pages 523-529
Circadian Patterns of Atrial Fibrillation Onset Mechanism: Can Pacing Be Influential?....Pages 530-535
Can Ventricular Rate Stabilisation Reduce Symptoms of Atrial Fibrillation?....Pages 536-541
Novel Pacing Algorithms Applied in Hybrid Therapies of Atrial Fibrillation: The Ultimate Solution?....Pages 542-546
Front Matter....Pages 547-547
Advanced Patient Management Using Knowledge-Based Systems....Pages 549-555
Single-Lead Dual Chamber Pacing: How Reliable and Effective Is It?....Pages 556-565
Hemodynamic Sensors: Are They All the Same?....Pages 566-575
Hemodynamic Sensors: What Clinical Value Do They Have in Heart Failure?....Pages 576-585
How Reliable and Effective Are Hemodynamic Sensors in Correcting Chronotropic Incompetence?....Pages 586-594
Hemodynamic Sensors: What Clinical Value Do They Have in Chronotropic Incompetence?....Pages 595-601
Hemodynamic Sensors: Clinical Value in Vasovagal Syncope....Pages 602-607
Sophisticated Pacemaker Diagnostics: Are They Really Useful in Clinical Practice?....Pages 608-612
Pacemaker Automaticity: Real Progress or Increased Complexity and Costs?....Pages 613-617
Pacemaker/ICD Lead Infection: What Are the Main Intracardiac Echocardiographic Features?....Pages 618-622
Percutaneous Extraction of Infected Pacemaker/ICD Leads: What Are the Current Technological Advances and Results?....Pages 623-630
Interference to Pacemaker/ICD Function by Commonly Encountered Electronic Devices: When and How Much to Worry About?....Pages 631-645
Biventricular Pacing: How to Predict the Clinical Response in the Single Patient?....Pages 646-653
Back Matter....Pages 655-657